Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
723415 participants
OBSERVATIONAL
1990-01-01
2025-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
NCT05088161
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147
Exploring the Mechanism of Severe Acute Pancreatitis Based on Metagenomics, Metabolomics and Proteomics
NCT06230432
Pancreatic Cancer Early Detection Program
NCT02206360
Personalized Precision Diagnosis and Treatment of Pancreatic Cancer
NCT04373928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pancreatic Cancer
Natural history
Natural history of pancreatic diseases
Pancreatitis
Natural history
Natural history of pancreatic diseases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Natural history
Natural history of pancreatic diseases
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis in 1990 through 2021
* Age 70+ years
Exclusion Criteria
* Other non-pancreatic diseases
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Huang Hai
Prof. Dr.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GePCPS-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.